Impact Pharmaceutical Services was acquired by Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, in February of 2022. Founded in 2009, the company operates within the Health Care and Pharmaceutical industries. Although specific details about the headquarters, last investment, and last investment investors are not available, Impact Pharmaceutical Services' acquisition by Syner-G reflects a significant development in the consolidation and growth of pharmaceutical service providers within the industry. This acquisition may offer investors insights and opportunities in the evolving landscape of pharmaceutical consulting and regulatory services.
Impact Pharmaceutical Services
General Information
Get notified when Impact Pharmaceutical Services moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Impact Pharmaceutical Services
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health Care
About Impact Pharmaceutical Services
No funding data available for Impact Pharmaceutical Services yet.
Get notified when Impact Pharmaceutical Services raises fundingImpact Pharmaceutical Services Alternatives & Competitors
To enable our clients to achieve success and enhance human health while inspiring our colleagues to...
Empowering pharmaceutical companies with advanced database management, statistical sales analytics,...
Mawdsleys is a global pharmaceutical wholesaler and service provider.
FAQ About Impact Pharmaceutical Services
Don't just browse. Track.
Signal Tracker monitors Impact Pharmaceutical Services and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
